Industry Veteran to Lead New Philanthropic Venture Fund Addressing Critical Early-Stage Funding Gap in Autoimmune Therapeutics and Diagnostics The Arthritis National Research Foundation (ANRF), a
Each year, the Arthritis National Research Foundation (ANRF) looks forward to joining the global rheumatology community at ACR Convergence, the American College of Rheumatology’s annual
New 501(c)(3) Subsidiary Will Provide Philanthropic Venture Capital for Proof-of-Concept Autoimmune Therapies and Diagnostics The Arthritis National Research Foundation (ANRF), a leading funder of early-stage
Vie Ventures welcomes additional strategic collaborators, expanding the coalition to morethan ten leading disease philanthropies focused on autoimmune and inflammatory disease Vie Ventures, a new
From early support to lasting impact, ANRF grants launch the careers of scientists who transform the future of rheumatology. For millions living with arthritis and
With expanded mechanisms and long-term impact, ANRF renews commitment to breakthrough, patient-focused science. IRVINE, CA – July 10, 2025 – The Arthritis National Research Foundation
Make a one-time or recurring donation and know you are making a difference by funding cutting-edge arthritis & related autoimmune disease research.
Industry Veteran to Lead New Philanthropic Venture Fund Addressing Critical Early-Stage Funding Gap in Autoimmune Therapeutics and Diagnostics The Arthritis National Research Foundation (ANRF), a
Each year, the Arthritis National Research Foundation (ANRF) looks forward to joining the global rheumatology community at ACR Convergence, the American College of Rheumatology’s annual
New 501(c)(3) Subsidiary Will Provide Philanthropic Venture Capital for Proof-of-Concept Autoimmune Therapies and Diagnostics The Arthritis National Research Foundation (ANRF), a leading funder of early-stage
800.588.2873
#: 95-6043953
5319 University Dr #10022
Irvine, CA 92612
